Table 4.
Other Organisms and Culture Confirmations
Organism | Specimen/sample type | Platform/assay (FDA no.) | Method | Target | Linear range (%)⁎ |
|
---|---|---|---|---|---|---|
Sensitivity | Specificity | |||||
HCV quantitative | EDTA plasma or serum | COBAS AmpliPrep/COBAS TaqMan HCV Test (P060030)† | Real-time RT-PCR | Transcript of a 244-base sequence in the highly conserved 5′ untranslated region of HCV; genotypes 1–6 | 43–69,000,000 IU/mL | |
Plasma or serum extracted from blood collected using EDTA or ACD | VERSANT HCV RNA 3.0 Assay (P020022)‡ | bDNA | 5′UTR and core regions of the HCV genome | 3200–40,000,000 IU/mL | ||
HCV qualitative | Plasma or serum | APTIMA HCV RNA Qualitative Assay (P020011)§ | Transcription- mediated amplification | 5′UTR of the HCV genome | 91.8–100 | 97.8–98.5 |
EDTA plasma or serum | AMPLICOR HCV test, version 2.0 (P000010)† | RT-PCR | 5′UTR of the HCV genome | 92–94 | 96–97 | |
EDTA plasma or serum | COBAS AMPLICOR HCV test, version 2.0 (P000012)† | RT-PCR | 5′UTR of the HCV genome | 92–94 | 96–97 | |
HBV quantitative | EDTA plasma or serum | COBAS TaqMan HBV Test (P050028)† | Real-time PCR | Core-precore region of the HBV genome; primer pairs to genotypes A–G of HBV and the precore mutation | 20–170,000,000 IU/mL | |
EDTA plasma or serum | RealTime HBV Assay (P080026)¶ | Real-time PCR | Surface (S) gene of the HBV genome; primer pairs to genotypes A–G of HBV | 10–1,000,000,000 IU/mL | ||
GBS | Vaginal and rectal swabs incubated in Lim broth overnight | BD MAX GBS assay and BD MAX System (K090191)∥ | Real-time PCR | 124-bp region of the cfb gene | 95 | 96.7 |
Vaginorectal swab | IDI-Strep B (K022504)∥ | Real-time PCR SmartCycler system⁎⁎ | GBS cfb gene | 94 | 95.9 | |
Vaginorectal swab | Xpert GBS (K060540)⁎⁎ | GeneXpert System (real-time PCR)⁎⁎ | 3′ region adjacent to the cfb gene | 91.1 | 96.0 | |
Directly from vaginal and rectal swabs or from LIM broth culture | Smart GBS test (K062948)⁎⁎ | Real-time PCR SmartCycler system⁎⁎ | DNA 3′ region adjacent to the cfb gene | Direct from swabs, 81.6 | Direct from swabs, 96.4 | |
From Lim broth, 98.7 | From Lim broth, 90.4 | |||||
Vaginal and rectal swabs incubated in Lim broth overnight | GBS PNA FISH (K082612)†† | PNA-FISH | 16S rRNA of Streptococcus agalactiae | 89.2–100 | 86.8–100 | |
Vaginal and anorectal swabs in Lim broth culture | AccuProbe Group B Streptococcus Culture Identification Kit (K974572)§ | Culture confirmation; hybridization protection assay | DNA probe that detects rRNA sequences unique to S. agalactiae | 97.5 | 99.8 | |
CA, GV, and TV | Vaginal sample | BD Affirm VPIII Microbial Identification Tests (K931374, K923133, K931151)∥ | Single-stranded DNA probes, hybridize with complementary rRNA target sequences to form hybrids | rRNA | CA, 80.6 | CA, 98.2 |
GV, 83.8 | GV, 99.1 | |||||
TV, 92.8 | TV, 99.9 | |||||
Group A Streptococcus | Throat swab | GASDirect Test (K924715)§ | Hybridization protection assay | rRNA | 91.7 | 99.3 |
Bacterial identification from culture | Cultures | AccuProbe Neisseria gonorrhoeae (K895583)§ | Hybridization protection assay | rRNA | 100 | 100 |
AccuProbe Listeria monocytogenes (K901397)§ | 100 | 99.7 | ||||
Organisms causing sepsis: GPCC | GPCC-positive cultures | BD GeneOhm StaphSR (K071026)∥ | Real-time PCR | SCCmec and mecA gene; nucA gene | MRSA % positive agreement, 100 | MRSA % negative agreement, 98.2–100 |
SA % positive agreement, 98.8–100 | SA % negative agreement, 96.5 | |||||
GPCC-positive cultures | Xpert MRSA/SA BC (K082140)⁎⁎ | GeneXpert System (real-time PCR)⁎⁎ | Spa and mecA genes and SCCmec inserted into S. aureus chromosomal attB insertion site | MRSA, 98.3 | MRSA, 99.4 | |
SA, 100 | SA, 98.6 | |||||
GPCC-positive cultures | S. aureus PNA FISH (K060099)†† | FISH assay | Species-specific 16S rRNA of S. aureus‡‡ | 100 | 100‡‡ | |
S. aureus/CNS PNA FISH (K092166)†† | ||||||
GPCC-positive cultures | AccuProbe S. aureus (K902213)§ | Hybridization protection assay | rRNA | 100 | 100 | |
Organisms causing sepsis: GPCPC | GPCPC-positive cultures | AccuProbe Streptococcus pneumoniae (K902908)§ | Hybridization protection assay | rRNA | 100 | 100 |
Organisms causing sepsis: GPCPC | GPCPC-positive cultures | E. faecalis/OE PNA FISH (K083074)†† | PNA; FISH assay | Species-specific 16S rRNA in E. faecalis and other enterococci§§ | % positive agreement with culture, 100 | % negative agreement with culture, 100 |
Organisms causing sepsis: smears from GNR | GNR-positive cultures | EC, PA | PNA; FISH assay | Species-specific rRNA of EC and PA | EC, 100 | 100¶¶ |
PNA FISH (K081309, K092236)†† | PA, 97.5 | 100 | ||||
GNR-positive cultures | EC, KP, PA PNA FISH (K101558)†† | PNA; FISH assay | Species-specific rRNA of EC, KP, and PA | EC, 100 | EC, 97.5 | |
KP, 98.7 | KP, 97.5 | |||||
PA, 96.9 | PA, 97.5 | |||||
Organisms causing sepsis: yeast | Smears made directly from yeast-positive blood cultures | Candida albicans PNA FISH (K062461)†† | PNA FISH species-specific probes | 16S rRNA of C. albicans | 100 | 100 |
Yeast Traffic Light PNA FISH (K080719)†† | ||||||
C. albicans/C. glabrata PNA FISH (K092784)†† | ||||||
Yeast-positive blood cultures | AccuProbe Blastomyces dermatitidis (K903201)§ | Hybridization protection assay | rRNA | 98.1 | 99.7 | |
AccuProbe Coccidiodes immitis (K904047)§ | 98.8 | 100 | ||||
AccuProbe Histoplasma capsulatum (K896859)§ | 100 | 100 | ||||
Mycobacterial identification from cultures | Growth from appropriate solid media or broth | AccuProbe M. avium (K896494)§ | Hybridization protection assay | rRNA | 99.3 | 100 |
AccuProbe M. avium complex (K897078)§ | 99.9 | 100 | ||||
AccuProbe Mycobacterium gordonae (K896492)§ | 98.8 | 99.7 | ||||
AccuProbe Mycobacterium intracellulare (K897077)§ | 100 | 100 | ||||
AccuProbe Mycobacterium kansasii (K904463)§ | 98.0 | 96.8 | ||||
AccuProbe MTB complex (K896493)§ | 99.2 | 99.9 | ||||
Mycoplasma species | Tissue culture | Mycoplasma Tissue Culture NI (MTC-NI) | DNA probe | rRNA of Mycoplasma and Acholeplasma species | Not applicable | Not applicable |
Rapid Detection System (K860574)§ |
ACD, anticoagulant citrate dextrose; bDNA, branched DNA; CA, Candida species; EC, Escherichia coli; GNR, Gram-negative rod; GPCC, Gram-positive cocci in clusters; GPCPC, Gram-positive cocci in pairs and chains; GV, Gardnerella vaginalis; KP, Klebsiella pneumonia; PA, Pseudomonas aeruginosa; TV, Trichomonas vaginalis.
Sensitivity, specificity, linearity range, and percentage positive or negative agreement with culture data are sourced from FDA submission material or product inserts.
Obtained from Roche Molecular Diagnostics, Pleasanton, CA.
Obtained from Siemens Healthcare Diagnostics, Deerfield, IL.
Obtained from Gen-Probe, Inc., San Diego, CA.
Obtained from Abbott Molecular, Inc., Des Plaines, IL.
Obtained from BD Diagnostics, Sparks, MD.
Obtained from Cepheid, Sunnyvale, CA.
Obtained from AdvanDx, Inc., Woburn, MA.
False-positive results with Staphylococcus schleiferi may occur because of a single-base mismatch.
Enterococcus moraviensis is identified as E. faecalis because of sequence identity.
False-positive results may occur with Shigella species (serogroups A, B, C, or D), Escherichia albertii, and Escherichia fergusonii because of sequence similarity.